EUVIMEDEUVIMED entdecken
Crossref

Metabolomic Profiling and Drug Interaction Characterization Reveal Riboflavin As a Breast Cancer Resistance Protein–Specific Endogenous Biomarker That Demonstrates Prediction of Transporter Activity In Vivo

Yueping Zhang, Petia A Shipkova, Bethanne M Warrack, David M Nelson, Linna Wang, Runlan Huo, Jian Chen, Erika Panfen, Xue-Qing Chen, R Marcus Fancher, Qian Ruan, Lisa J Christopher und 3 weitere

Drug Metabolism and Disposition · 2023

DOI: 10.1124/dmd.123.001284 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Metabolism and Disposition, 2023. Verfasst von Yueping Zhang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Drug Metabolism and Pharmacokinetics (Y.Z., E.P., R.M.F., M.S., H.S.), Bioanalytical Research (P.A.S., B.M.W.), Translational Developm…. Hauptthemen laut MEDLINE: Brain, Breast Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 51 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BrainBreast NeoplasmsHumansMiceAnimalsFemaleATP Binding Cassette Transporter, Subfamily G, Member 2ATP-Binding Cassette TransportersNeoplasm ProteinsATP Binding Cassette Transporter, Subfamily BATP Binding Cassette Transporter, Subfamily B, Member 1Mice, KnockoutBiomarkersDrug Interactions

Substanzen

ATP Binding Cassette Transporter, Subfamily G, Member 2ATP-Binding Cassette TransportersNeoplasm ProteinsATP Binding Cassette Transporter, Subfamily BATP Binding Cassette Transporter, Subfamily B, Member 1Biomarkers

Autor:innen und Institutionen

  • Departments of Drug Metabolism and Pharmacokinetics (Y.Z., E.P., R.M.F., M.S., H.S.), Bioanalytical Research (P.A.S., B.M.W.), Translational Development (D.M.N.), Nonclinical Disposition and Bioanalysis (L.W., R.H., J.C…

Zitieren

APA

Zhang, Y., Shipkova, P. A., Warrack, B. M., Nelson, D. M., Wang, L., Huo, R., Chen, J., Panfen, E., Chen, X. Q., Fancher, R. M., Ruan, Q., Christopher, L. J., Xue, Y., Sinz, M., & Shen, H. (2023). Metabolomic Profiling and Drug Interaction Characterization Reveal Riboflavin As a Breast Cancer Resistance Protein–Specific Endogenous Biomarker That Demonstrates Prediction of Transporter Activity In Vivo. Drug Metabolism and Disposition. https://doi.org/10.1124/dmd.123.001284

Vancouver

Zhang Y, Shipkova PA, Warrack BM, Nelson DM, Wang L, Huo R, et al. Metabolomic Profiling and Drug Interaction Characterization Reveal Riboflavin As a Breast Cancer Resistance Protein–Specific Endogenous Biomarker That Demonstrates Prediction of Transporter Activity In Vivo. Drug Metabolism and Disposition. 2023. doi:10.1124/dmd.123.001284

BibTeX
@article{Zhang2023,
  author = {Zhang, Yueping and Shipkova, Petia A and Warrack, Bethanne M and Nelson, David M and Wang, Linna and Huo, Runlan and Chen, Jian and Panfen, Erika and Chen, Xue-Qing and Fancher, R Marcus and Ruan, Qian and Christopher, Lisa J and Xue, Yongjun and Sinz, Michael and Shen, Hong},
  title = {Metabolomic Profiling and Drug Interaction Characterization Reveal Riboflavin As a Breast Cancer Resistance Protein–Specific Endogenous Biomarker That Demonstrates Prediction of Transporter Activity In Vivo},
  journal = {Drug Metabolism and Disposition},
  year = {2023},
  doi = {10.1124/dmd.123.001284}
}
Kostenlos starten →